Experimental Therapeutics
The Experimental Therapeutics (ET) Program’s research has a strong clinical and translational orientation, aligned along two main research themes:
- Drug discovery and delivery
- Clinical research
Within those themes, the program has these specific aims:
- Providing new approaches to individualized cancer treatment such as targeted drug delivery systems, novel chemotherapeutics, improved imaging and image-guided techniques, and the most up-to-date clinical treatments via clinical trials
- Fostering translation of discoveries between the laboratory and clinic through collaborations and scientific synergy among HCI members
- Promoting specialized initiatives in quantitative, molecular, and pre-clinical imaging
- Developing and executing investigator-initiated therapeutic, imaging, and imaging-guided clinical trials to establish new treatments for patients
Program Membership
HCI Cancer Center members enjoy a variety of benefits, including eligibility for leadership roles in the Center, institutional funding opportunities, and scientific/administrative support.
